The Evolution Of Cal/BD Fixed Dose Combination Therapy For Psoriasis: A Case Study And Discussion
A fourteen-year-old boy presented with itchy thick red scaly plaques on his scalp, arms, legs, and torso. They had been present since the age of seven.
A fourteen-year-old boy presented with itchy thick red scaly plaques on his scalp, arms, legs, and torso. They had been present since the age of seven.
Psoriasis is a chronic immune-mediated skin disease with a variety of morphological presentations, distribution patterns and severities.
Plaque psoriasis is a chronic, recurrent, immune-mediated, inflammatory skin disease that can have a significant negative impact on patient and family quality of life.
Biostimulatory fillers, such as calcium hydroxylapatite (CaHA), have been used for more than a decade for facial voluminization and HIV-induced lipoatrophy.
Dermatology is experiencing an explosion of new therapies targeting the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway.
Rosacea is a well-described chronic cutaneous syndrome with a constellation of different clinical signs and symptoms, with key components including persistent facial erythema and inflammatory papules and pustules primarily affecting the central face, and often with repeated remissions and exacerbations.
The modern era of psoriasis treatment has provided dermatologists with an array of systemic medications to address this serious inflammatory skin disease.
Post-inflammatory hyperpigmentation (PIH) is a common, acquired pigmentary condition. Although it can occur in all skin phototypes, it more commonly affects individuals with darker skin phenotypes.
Bullous pemphigoid (BP) is the most common autoimmune blistering condition. It preferentially affects the elderly population between the ages of 60 to 80.